Journal
MOLECULAR GENETICS & GENOMIC MEDICINE
Volume 10, Issue 7, Pages -Publisher
WILEY
DOI: 10.1002/mgg3.1940
Keywords
Chinese; germline mutation; hereditary breast and ovarian cancer
Categories
Funding
- Dr. Ellen Li Charitable Foundation
- Kerry Kuok Foundation
- Health and Medical Research Fund [03143406]
- Asian Fund for Cancer Research and Hong Kong Hereditary Breast Cancer Family Registry
Ask authors/readers for more resources
Identifying genetic mutations related to hereditary breast and ovarian cancer in Chinese patients has significant impacts on patient management and expanding screening options.
Background: Ovarian and breast cancers are known to have significant genetic components. Considering the differences in the mutation spectrum across ethnicity, it is important to identify hereditary breast and ovarian cancer (HBOC) genes mutation in Chinese for clinical management. Methods: Two cohorts of 451 patients with ovarian cancer only (OV) and 93 patients with both breast and ovarian (BROV) cancers were initially screened for BRCA1, BRCA2, TP53, and PTEN. 109 OV and 43 BROV patients with extensive clinical risk and were being tested negative, were then further characterized by 30-gene panel analysis. Results: Pathogenic BRCA1/2 variants were identified in 45 OV patients and 33 BROV patients, giving a prevalence of 101 and 35.5%, respectively. After the extended screening, mutations in other HBOC genes were identified in an additional 12.8% (14/109) of the OV cohort and 14% (6/43) in the BROV cohort. The most commonly mutated genes in the OV cohort were MSI12 (4.6%) while in the BROV cohort were MSH2 (4.7%) and PALB2 (4.7%). With this extended multigene testing strategy, pathogenic mutations were detected in 12.8% of OV patients (BRCAs: 10%; additional genes: 12.8%) and 40.9% (BRCAs: 35.5%; additional genes: 14%) of BROV patients. Conclusion: Extended characterization of the contributions of HBOC genes to OV and BROV patients has significant impacts on further management in patients and their families, expanding the screening net for more asymptomatic individuals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available